Hsa-miR-375 promotes the progression of inflammatory bowel disease by upregulating TLR4.

CONCLUSIONS: Hsa-miR-375 is involved in the pathogenesis of IBD by upregulating TLR4 and inducing NF-κB activation.
PMID: 31539144 [PubMed - in process]

Source: European Review for Medical and Pharmacological Sciences - September 22, 2019 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research